Episode Details
Back to EpisodesIridex Reports Q4 Losses, Eyes Fiscal Year Growth
Description
Iridex Corporation, a Mountain View-based medical laser firm, posted Q4 losses of $184,000, or $0.01 per share, with $14.7 million in revenue. Full-year losses reached $4.4 million, or $0.26 per share, with $52.7 million in revenue. Despite sector pressures, Iridexs focus on eye and other treatments lasers keeps it relevant. As it enters the new fiscal year, analysts will monitor its progress.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/215ca0455c31fb39